Page 834 - Withrow and MacEwen's Small Animal Clinical Oncology, 6th Edition

812 Index

Alimentary lymphoma (Continued) Amputation Antimetabolites, 193–194
treatment and prognosis, 721–723 for canine osteosarcoma, 534, 536f cytosine arabinoside, 193–194
intermediate- or high-grade alimentary
5-fluorouracil, 194
for osteosarcoma, 171
VetBooks.ir large granular lymphoma, 722 Anal sac apocrine adenocarcinoma, fine-needle gemcitabine, 194
lymphoma, 721–722, 722t
aspiration of, 136f
methotrexate, 193–194
low-grade alimentary lymphoma, 721 Anal sac tumor, apocrine gland of, 134 Antimicrotubule agent, 194–195
role of radiation therapy in cats with Analgesic taxanes, 195
gastrointestinal lymphoma, 723 combination, 295 vinca alkaloids, 195
role of surgery in cats with types of, 292t Antioxidant, 309–310
gastrointestinal lymphoma, Anaphase, 36 Antitumor antibiotic, 192–193
722–723 Anaplasia, 62–63 actinomycin D, 193
supportive care for cats with Anaplastic colonic carcinoma, 132f doxorubicin, 192–193
gastrointestinal lymphoma, 723 Anaplastic lymphoma kinase gene (ALK), 4–5 mitoxantrone, 193
ALK. see Anaplastic lymphoma kinase gene Androgen, 19, 631 Antitumor immunity, augmentation of, in
Alkaline phosphatase (ALP) Androgen-independent tumor, 92 gross metastatic disease, 547
in canine osteosarcoma, 532–533, 532f Anemia, 99b Apocrine adenocarcinoma, 134
for osteoblast identification, 129 causes and types of, 102–103 Apocrine gland adenoma, 359
Alkylating agent, 190–192 Anemia of chronic disease (ACD), 103 Apocrine gland anal sac adenocarcinoma,
chlorambucil, 267 Aneuploidy theory, 7 470–476
dacarbazine, 192 Aneurysmal bone cysts (ABCs), 553 comparative aspects for, 476–477
nitrogen mustards Angelica sinensis, 332 diagnostic technique for, 471–472, 473f
chlorambucil, 191 Angiogenesis, 52f history and clinical signs for, 471, 472f
cyclophosphamide, 190–191 cancer and, 6–7 incidence and risk factors for, 470
ifosfamide, 191 inducing, 6–7 pathology and natural behavior for, 470–471
mechlorethamine, 190 inhibition of, 269–270 prognosis for, 475–476, 476f
melphalan, 190 malignant bone marrow disorder treatment for, 472–475, 473f
nitrosoureas, 191–192 and, 263 Apocrine gland carcinoma, 359
lomustine, 191 metastasis and, 47–48 Apocrine gland of the anal sac tumor, 134
streptozotocin, 191–192 occurrence of, 263 Apoptosis
procarbazine, 192 principle of, 263 cancer and, 6
Allograft limb salvage surgery, for canine receptor tyrosine kinase signaling and, 258 characteristics of, 39
osteosarcoma, 535–537, 537f Angiogenic switch, 47–48 of endothelial cells, 211
Alopecia Animal Clinical Investigation (ACI), 346 mediators of, 39f
causes and signs of, 105 Animal companionship, 310 role of, 46
Malassezia-associated dermatitis and, 105 client expectations and, 311 Appetite stimulation, pharmacologic, 304
tumors associated with, 99b Animal Medicinal Drug Use Clarification Act Aqueous quick stain, 128–129
ALP. see Alkaline phosphatase of 1994, 345 Arachidonic acid (AA), 308f
Alpha/beta model, for cell death, 214f Animal Tumor Registry, 83t Arginine, 308
Alpha/beta ratio, 214, 214f Anisocytosis, 63 Argyrophilic nucleolar organizer region
Alpha fetoprotein (AFP), 597 malignancy and, 131 (AgNOR), 385–386
ALVAC, 240 in squamous cell carcinoma, 133f Array analysis, 147f
Amantadine Anisokaryosis, 63 Asbestos, 17
dose and effects of malignancy and, 131 Asian/medicinal mushrooms, 333
for cats, 293t–294t in squamous cell carcinoma, 133f L-Asparaginase, 197
for dogs, 292t Anoikis, 6 Aspiration
NSAIDs and, 296 metastatic cancer cell survival and, 53 sampling hemorrhage from, 130
Amelanotic melanoma, 369f Anterior uveal melanomas, 680 of submandibular salivary gland, 129–130
Amino acid, 305–306 Antiangiogenic therapy technique for, 126
change, 259–260 adverse events for, 267–268 Aspirin, 293t–294t
protein and, 308 antitumor effects of, 263–264 Assisted enteral nutrition, 304–305
Aminobisphosphonates, for primary and biomarkers for, 268 Astaxanthin, 309
metastatic bone cancer pain, 548–549 cancer and, 6–7 Astrocytic tumors, 658t
Amitriptyline types of, 263 Astrocytoma, 666t
dose and effects of Antibody-dependent cell-mediated “Asynchronous maturation”, 133
for cats, 293t–294t cytotoxicity (ADCC), 240 Autophagosome, 6
for dogs, 292t Antibody therapy, for cancer, 240–241 Autophagy, 6
efficacy of, 296 Anticancer drug role of, 46
AML. see Acute myelogenous leukemia basis of, 182 Autophosphorylation, 257–258
Amoeboid invasion, 52 safety concerns for, 188 Avian leukosis virus, 41
AMP. see Adenosine monophosphate Anticonvulsant drug, 296 5-Azacytidine (Vidaza), 269
Amphicrine cells, 582 Antidiuretic hormone (ADH), 100 5-Aza-deoxycitidine (decitabine, Dacogen), 269
Amplification, 40f, 42 Antigrowth signal, insensitivity to, 46 Azotemia, 100